Rosa Alba Abellás-Sequeiros
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rosa Alba Abellás-Sequeiros has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- José Ramón González-Juanatey
Cellular and Molecular Cardiology Research Unit IDIS (Instituto de Investigación Sanitaria de Santiago de Compostela), Complexo Hospitalario Universitario de Santiago de Compostela, Área Sanitaria Santiago de Compostela e Barbanza (SERGAS) Santiago de Compostela A Coruña Spain
3 shared publications - Ramiro Trillo-Nouche
Servicio de Cardiología, Hospital Clínico Universitario de Santiago, Instituto de Investigación Sanitaria de Santiago de Compostela (IDICHUS), y CIBERCV, Santiago de Compostela, Spain
2 shared publications Raymundo Ocaranza-Sánchez
Interventional Cardiology Unit, Cardiology Department, Lucus Augusti Universitary Hospital, Lugo, Spain
2 shared publicationsA. Redondo-Diéguez
Department of Cardiology and Coronary Care Unit, University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain
1 shared publicationBelen Cid-Alvarez
Interventional Cardiology Unit, Universitary Clinical Hospital of Santiago de Compostela, 15706, Spain
1 shared publicationCarlos Galvão Braga
Interventional Cardiology Unit, Hospital de Braga, 4710 Braga, Portugal
1 shared publication
Latest Publications
- 12 February 2021
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 32 (6) , 586-587
First-in-man reported 12-months follow-up after intravascular lithotripsy in left main percutaneous revascularization
Although intravascular lithotripsy (IVL) in percutaneous coronary intervention (PCI) of severely calcified left main disease has been suggested to be effective and well-tolerated in the immediate post-intervention period, there are no data available regarding its long-term efficacy. Eight patients with high-risk left main disease (mean syntax score of 33) were treated with IVL in our center with no hemodynamic alterations or arrhythmias during the treatment. The success rate of the procedure was 100%. The major adverse cardiovascular events rate at 12 months was 12.5%, due to one case of target-lesion revascularization. There were no deaths, stroke or stent thromboses. So, after 12 months of follow-up, intravascular lithotripsy as an adjuvant to LM-PCI appears to be effective and safe.
- 12 February 2021
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 32 (6) , 586-587
First-in-man reported 12-months follow-up after intravascular lithotripsy in left main percutaneous revascularization
Although intravascular lithotripsy (IVL) in percutaneous coronary intervention (PCI) of severely calcified left main disease has been suggested to be effective and well-tolerated in the immediate post-intervention period, there are no data available regarding its long-term efficacy. Eight patients with high-risk left main disease (mean syntax score of 33) were treated with IVL in our center with no hemodynamic alterations or arrhythmias during the treatment. The success rate of the procedure was 100%. The major adverse cardiovascular events rate at 12 months was 12.5%, due to one case of target-lesion revascularization. There were no deaths, stroke or stent thromboses. So, after 12 months of follow-up, intravascular lithotripsy as an adjuvant to LM-PCI appears to be effective and safe.
- 1 September 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 219, 264-270
“Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients”
- 1 September 2016
- Published by Elsevier in International Journal of Cardiology
- Vol. 219, 264-270
“Assessment of effectiveness and security in high pressure postdilatation of bioresorbable vascular scaffolds during percutaneous coronary intervention. Study in a contemporary, non-selected cohort of Spanish patients”
- Open Access
- 1 July 2016
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 35 (7-8) , 453-454
Optical coherence tomography images of three different overlapping stents
- 1 July 2016
- Published by Elsevier in Revista Portuguesa de Cardiologia
- Vol. 35 (7-8) , 453-454
Open AccessOptical coherence tomography images of three different overlapping stents
- 1 March 2016
- Published by Elsevier in Journal of Cardiology
- Vol. 67 (3) , 262-267
Mehran contrast nephropathy risk score: Is it still useful 10 years later?
- 1 March 2016
- Published by Elsevier in Journal of Cardiology
- Vol. 67 (3) , 262-267
Mehran contrast nephropathy risk score: Is it still useful 10 years later?
- Open Access
- 31 October 2015
- Published by ClinMed International Library in International Journal of Clinical Cardiology
- Vol. 2 (5)
Arrhythmic Manifestation of Prinzmetal' Sangina Induced by Therapeutic Hypothermia
Variant angina was first described by Prinzmetal et al. [1] like an episode of chest pain with transient ST-segment elevation. However, about 80% of patients course in an asymptomatic way [2]. In other cases, syncopeor sudden cardiac death are the mainly manifestation.
- 31 October 2015
- Published by ClinMed International Library in International Journal of Clinical Cardiology
- Vol. 2 (5)
Open AccessArrhythmic Manifestation of Prinzmetal' Sangina Induced by Therapeutic Hypothermia
Variant angina was first described by Prinzmetal et al. [1] like an episode of chest pain with transient ST-segment elevation. However, about 80% of patients course in an asymptomatic way [2]. In other cases, syncopeor sudden cardiac death are the mainly manifestation.